Dr. Bahl is investigating how the RasGRP1-mTORC1 pathway leads to an altered metabolic state in naïve T cells and how it functions in leukemia and other cancer types.
Dr. Bahl is investigating how the RasGRP1-mTORC1 pathway leads to an altered metabolic state in naïve T cells and how it functions in leukemia and other cancer types.